Michelle Dipp is the Co-Founder and Managing Partner at Biospring Partners. See portfolio, sector focus and contact routes.
Michelle Dipp is the Co-Founder and Managing Partner at Biospring Partners, a New York-based venture capital firm, with over a decade of private equity and venture capital expertise in life sciences. She holds an M.D. and Ph.D. from the University of Oxford, having previously served as a Managing Director at General Atlantic and co-founded Longwood Fund before joining GSK as a senior executive. Biospring Partners focuses on life sciences investments, though specific stage, sector, and geographic thesis details are not explicitly detailed in available sources beyond this focus. The firm’s inaugural investment was a $10 million commitment to UK pharmaceutical company Abzena, where Dipp serves on the board of directors. Notable portfolio companies include Abzena and Kiniciti, for which Dipp also serves on the board. While Dipp is passionate about investments that drive success in life sciences, no distinctive public writing or unique point of view is documented in the provided search results.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in New York.
Investors like Michelle Dipp · Full investor directory · Investor access · Company funding database